Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOvoca Bio Regulatory News (OVB)

  • There is currently no data for OVB

Half-year Report

30 Sep 2025 07:00

RNS Number : 3030B
Ovoca Bio PLC
30 September 2025
 

Ovoca Bio PLC

30 September 2025

 

Ovoca Bio plc

 

("Ovoca" or the "Company")

 

Interim Results for the six months ended 30 June 2025

 

Dublin, Ireland, 30 September 2025 - Ovoca Bio announces its interim financial statements and report covering the six-months ending 30 June 2025.

 

Please click on the following link to view the full Half Year Report and extracts are set out at the end of this announcement:

 

Ovoca News - Ovoca Bio

 

CEO Statement

Today we have published Ovoca's financial statements covering the six-month period to the end of June 2025, which I encourage all stakeholders to read. On 7 May 2025 the Company entered into a conditional Letter of Intent ("LOI") to acquire 100% of Tadeen International Limited ("Tadeen"), a UK-registered company, which indirectly owns 100% of a portfolio of mineral exploration licenses in Morocco prospective for Copper and Silver (the "Proposed Acquisition"). The team at Ovoca has been working to complete the Proposed Acquisition and in due course further announcements will be made as we finalize the acquisition of Tadeen.

 

As at 30 June 2025, the Company had cash and cash equivalents amounting to €1,526 million ($ 1,788 million) and we will continue to carefully manage our financial resources. The costs incurred during the period relate to the costs of work in relation to the Proposed Acquisition along with corporate costs.

 

I would like to thank the management team of the Company and the Board of Directors for their support.

 

End

 

For further information:

 

Ovoca Bio plc

Tim McCutcheon (Chief Executive Officer)

Tel +353 1 661 9819

info@ovocabio.com

 

Beaumont Cornish Limited (Nominated Adviser and Broker)

James Biddle/ Roland Cornish

Tel: +44 (0) 207 628 3396

 

Nominated Adviser Statement

 

Beaumont Cornish Limited ("Beaumont Cornish"), is the Company's Nominated Adviser and is authorised and regulated in the United Kingdom by the Financial Conduct Authority. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other person for providing the protections afforded to customers of Beaumont Cornish nor for advising them in relation to the transaction and arrangements described in the announcement or any matter referred to in it.

 

Half Year Report

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR EANNNAAXSEFA
Date   Source Headline
20th Dec 201212:23 pmRNSHolding(s) in Company
11th Dec 20127:00 amRNSProposed Disposal
28th Sep 20127:00 amRNSInterim Results
29th Aug 20127:00 amRNSOperational Update
6th Jul 20127:00 amRNSOperational Update
19th Jun 20123:39 pmRNSDirector/PDMR Shareholding
13th Jun 20124:00 pmRNSDirector/PDMR Shareholding
28th May 20123:43 pmRNSDirector/PDMR Shareholding
14th May 20129:41 amRNSResult of AGM
3rd May 20127:00 amRNSManagement Change - Appointment of New CEO
13th Apr 20127:00 amRNSDirector Appointment
12th Apr 20129:38 amRNSAnnual Report
5th Apr 20125:15 pmRNSOlcha Exploitation License Granted
6th Feb 20124:15 pmRNSDirector/PDMR Shareholding
3rd Feb 20127:00 amRNSOperational Update
10th Oct 20117:00 amRNSOlcha Certificate of Discovery
29th Sep 20117:00 amRNSInterim Results
25th Jul 20117:00 amRNSTransaction in Own Shares
20th Jul 201112:30 pmRNSChange of Registered Office
20th Jul 20117:00 amRNSTransaction in Own Shares
18th Jul 20117:00 amRNSTransaction in Own Shares
14th Jul 20117:00 amRNSTransaction in Own Shares
12th Jul 20117:00 amRNSTransaction in Own Shares
11th Jul 20117:00 amRNSDirector/PDMR Shareholding
7th Jul 20117:00 amRNSResource Update
5th Jul 20117:00 amRNSAppointment of Joint Broker
21st Jun 20117:00 amRNSResult of AGM
17th Jun 20111:49 pmRNSTransaction in Own Shares
8th Jun 20117:00 amRNSTransaction in Own Shares
7th Jun 201110:45 amRNSHolding(s) in Company
1st Jun 20117:00 amRNSShare Buy Back
23rd May 20117:00 amRNSAnnual Report
31st Mar 20117:00 amRNSOperational and Corporate Update
25th Feb 20117:00 amRNSDrilling Update
22nd Feb 20117:00 amRNSDirector Appointment
21st Feb 20117:00 amRNSDrilling Update
2nd Feb 20114:17 pmRNSCorrection - Resource Update
2nd Feb 20117:00 amRNSResource Update
7th Dec 20107:00 amRNSOperational and corporate update
15th Nov 20107:00 amRNSOperational Update
27th Oct 20107:00 amRNSDrilling Update
27th Oct 20107:00 amRNSDrilling Update
30th Sep 20107:00 amRNSInterim Results
20th Sep 20109:01 amRNSDisposal
31st Aug 20107:00 amRNSDrilling Update
26th Jul 20103:30 pmRNSResult of AGM and EGM
2nd Jul 20103:43 pmRNSDocument Availability
29th Jun 20103:30 pmRNSAnnual Financial Report
21st Jun 20107:00 amRNSDrilling Update
25th May 20107:00 amRNSProposed Share Buy Back

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.